80 related articles for article (PubMed ID: 4153242)
1. [Stimulators of the beta-adrenergic receptors in the therapy of bronchial asthma].
Smolenskiĭ VS; Daniliak IG; Zaslavskiĭ ML
Sov Med; 1974 Jul; 0(7):91-5. PubMed ID: 4153242
[No Abstract] [Full Text] [Related]
2. [Bronchial asthma: factors which contribute to "intractable asthma" and approach to new treatments, from the standpoint of the bronchial pathophysiology].
Satake T
Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Sep; 23(9):971-80. PubMed ID: 2869175
[No Abstract] [Full Text] [Related]
3. Beta adrenergic receptors of polymorphonuclear particulates in bronchial asthma.
Galant SP; Duriseti L; Underwood S; Allred S; Insel PA
J Clin Invest; 1980 Mar; 65(3):577-85. PubMed ID: 6101600
[TBL] [Abstract][Full Text] [Related]
4. [Use of beta-adrenostimulators in patients with bronchial asthma].
Kukes VG; Sivkov II; Aleksa VI; Tsoĭ AN; Duranté TO
Klin Med (Mosk); 1974 Dec; 52(12):90-4. PubMed ID: 4155462
[No Abstract] [Full Text] [Related]
5. Salmeterol for nocturnal asthma.
Bryan S
J Fam Pract; 1999 Jun; 48(6):415-6. PubMed ID: 10386478
[No Abstract] [Full Text] [Related]
6. [Salbutamol as a beta-adrenergic stimulator in bronchospastic pulmonary conditions].
Dano P; Falholt W
Ugeskr Laeger; 1971 Apr; 133(15):685-8. PubMed ID: 4396922
[No Abstract] [Full Text] [Related]
7. Combined theophylline/beta-agonists maintenance therapy in chronic asthma.
Eriksson NE; Haglind K; Ewald U
Eur J Respir Dis; 1983 Apr; 64(3):172-7. PubMed ID: 6132832
[TBL] [Abstract][Full Text] [Related]
8. [The therapeutic potentials of Berotec-100 in bronchial asthma patients].
Emel'ianov AV; Shevelev SE; Shubin SA; Sinitsina TM; Fedoseev GB
Klin Med (Mosk); 1998; 76(7):38-9. PubMed ID: 9742777
[No Abstract] [Full Text] [Related]
9. [Comparative effects of a new beta-adrenergic stimulant in asthma].
Gayrard P; Orehek J; Charpin J
Presse Med (1893); 1970 Dec; 78(52):2337-8. PubMed ID: 4395151
[No Abstract] [Full Text] [Related]
10. Peripheral airway function in childhood asthma, assessed by single-breath He and SF6 washout.
Ljungberg HK; Gustafsson PM
Pediatr Pulmonol; 2003 Oct; 36(4):339-47. PubMed ID: 12950049
[TBL] [Abstract][Full Text] [Related]
11. [Sensitivity of the bronchopulmonary apparatus to the inhalation of biologically active substances in different forms of bronchial asthma].
Proshchalykin AI; Gushchin IS
Sov Med; 1978 Apr; (4):64-9. PubMed ID: 26117
[No Abstract] [Full Text] [Related]
12. [Treatment of bronchial asthma with small doses of papaverine combined with beta stimulators].
Krasnowska M; Jankowska R
Pneumonol Pol; 1982; 50(1-2):21-4. PubMed ID: 7122246
[No Abstract] [Full Text] [Related]
13. Status of inhalation therapy in bronchial asthma in adults above twelve years of age in armed forces.
Barthwal MS; Deoskar RB; Rajan KE
J Assoc Physicians India; 2005 Aug; 53():681-4. PubMed ID: 16398075
[TBL] [Abstract][Full Text] [Related]
14. When should a reversibility test be performed on patients with early stages of asthma and normal spirometry?
Sposato B; Mariotta S; Ricci A
J Asthma; 2008 Aug; 45(6):479-83. PubMed ID: 18612900
[TBL] [Abstract][Full Text] [Related]
15. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
[TBL] [Abstract][Full Text] [Related]
16. Long-and short-acting beta 2-adrenergic agonists. Effects on airway function in patients with asthma.
Busse WW
Arch Intern Med; 1996 Jul; 156(14):1514-20. PubMed ID: 8687259
[TBL] [Abstract][Full Text] [Related]
17. Asthma control in a random sample of New Zealand adolescent asthmatics.
van Dalen CJ; Harding E; Parkin J; Blakey K; Cheng S; Pearce NE; Douwes J
J Asthma; 2007 May; 44(4):261-6. PubMed ID: 17530523
[TBL] [Abstract][Full Text] [Related]
18. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
19. [Progress in the symptomatic treatment of bronchial asthma].
Jäger L
Z Erkr Atmungsorgane Folia Bronchol; 1972 Apr; 136(2):231-45. PubMed ID: 4403663
[No Abstract] [Full Text] [Related]
20. [New beta-adrenergic receptor stimulators in the symptomatic treatment of asthma and chronic obstructive bronchial diseases].
Van Der Straeten M; Lamont H; Pauwels R; Tasson J
Acta Tuberc Pneumol Belg; 1974; 65(3-4):384-94. PubMed ID: 4156900
[No Abstract] [Full Text] [Related]
[Next] [New Search]
